Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke

Clinical trial NCT07047014 · RECRUITING

Trial details

NCT number: NCT07047014
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Stroke, Ischemic Medium Vessel Occlusions

Start date: 2025-07-30
Primary completion: 2027-03-30
Enrollment: 596

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.